Centaurus Financial Inc. Acquires Shares of 4,955 Axon Enterprise, Inc $AXON

Posted by Francis Steltz on Aug 28th, 2026

Centaurus Financial Inc. acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 4,955 shares of the biotechnology company’s stock, valued at approximately $2,778,000.

Other institutional investors have also modified their holdings of the company. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise during the 4th quarter worth approximately $28,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $31,000. AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at approximately $34,000. Darwin Wealth Management LLC bought a new position in Axon Enterprise during the second quarter worth $37,000. Finally, Strive Financial Group LLC bought a new position in Axon Enterprise during the fourth quarter worth $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $611.20 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The firm has a market capitalization of $49.65 billion, a PE ratio of 253.61, a P/E/G ratio of 9.86 and a beta of 1.39. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $794.29. The business’s fifty day moving average price is $557.20 and its two-hundred day moving average price is $482.16.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company’s quarterly revenue was up 35.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.12 earnings per share. On average, research analysts expect that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on AXON. Piper Sandler boosted their target price on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price target on shares of Axon Enterprise in a report on Thursday, June 25th. UBS Group boosted their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $730.92.

View Our Latest Analysis on Axon Enterprise

Insider Activity

In other Axon Enterprise news, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the transaction, the insider owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the sale, the executive owned 49,710 shares in the company, valued at $24,855,000. The trade was a 2.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 76,594 shares of company stock worth $41,236,386 over the last three months. Insiders own 4.20% of the company’s stock.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.